Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know [Yahoo! Finance]
Artivion, Inc. (AORT)
Company Research
Source: Yahoo! Finance
This change raises the revenue that insurance companies receive per patient from federal funds without increasing their costs. This is projected to improve profit margins for major providers like UnitedHealth and Humana. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Among others, the following stocks were impacted: Medical Devices & Supplies - Cardiology, Neurology, Vascular company Artivion (NYSE:AORT) jumped 3.6%. Is now the time to buy Artivion? Access our full analysis report here, it's free. Generic Pharmaceuticals company ANI Pharmaceuticals (NASDAQ:ANIP) jumped 3.9%. Is now the time to buy ANI Pharmaceuticals? Access our full analysis report here, it's free. Healthcare Technology for Providers company Privia Health (NASDAQ:PRVA) jumped 3.5%. Is now the time to buy Privia Health? Access our full analysis report here, it's free. Zooming In On ANI Pharmaceuticals (ANIP) ANI Pharmaceuticals's share
Show less
Read more
Impact Snapshot
Event Time:
AORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AORT alerts
High impacting Artivion, Inc. news events
Weekly update
A roundup of the hottest topics
AORT
News
- How The Investment Story Is Shifting For Artivion (AORT) After Recent Analyst And FDA Updates [Yahoo! Finance]Yahoo! Finance
- 1 Stock Under $50 to Own for Decades and 2 We Avoid [Yahoo! Finance]Yahoo! Finance
- Artivion (AORT) was upgraded by LADENBURG THALM/SH SH from "neutral" to "buy". They now have a $42.00 price target on the stock.MarketBeat
- Artivion Secures FDA Approval for NEXUS Aortic Arch System [Yahoo! Finance]Yahoo! Finance
- Artivion (AORT) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $58.00 price target on the stock.MarketBeat
AORT
Earnings
- 2/12/26 - Beat
AORT
Sec Filings
- 4/1/26 - Form ARS
- 4/1/26 - Form DEFA14A
- 4/1/26 - Form DEF
- AORT's page on the SEC website